{
    "Trade/Device Name(s)": [
        "Lin-Zhi International, Inc. (LZI) Methamphetamine Enzyme Immunoassay for Pictus Analyzers"
    ],
    "Submitter Information": "Diatron, US, Inc.",
    "510(k) Number": "K201442",
    "Predicate Device Reference 510(k) Number(s)": [
        "K113661"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LAF"
    ],
    "Summary Letter Date": "July 31, 2020",
    "Summary Letter Received Date": "June 1, 2020",
    "Submission Date": "May 29, 2020",
    "Regulation Number(s)": [
        "21 CFR 862.3610"
    ],
    "Regulation Name(s)": [
        "Methamphetamine Test System"
    ],
    "Analyte Class(es)": [
        "toxicology"
    ],
    "Analyte(s)": [
        "d-methamphetamine"
    ],
    "Specimen Type(s)": [
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Pictus Analyzers",
        "Diatron Pictus 700 Analyzer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay",
        "Photometric detection"
    ],
    "Methodologies": [
        "Homogeneous enzyme immunoassay"
    ],
    "Submission Type(s)": [
        "Assay",
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for LZI Methamphetamine Enzyme Immunoassay for qualitative detection of d-methamphetamine in urine using Pictus Analyzers",
    "Indications for Use Summary": "Qualitative determination of d-methamphetamine in human urine at a cutoff value of 500 ng/mL as a rapid screening procedure; results are preliminary and require confirmation by GC/MS or LC/MS.",
    "fda_folder": "Toxicology"
}